Abstract
This project aims to synthesize N-(2,6-dimethylphenyl)chloroacetamide, a key intermediate in the synthesis route of Ranolazine, a medication used in the treatment of angina, characterized by temporary chest pain due to a lack of oxygen in the cardiac muscle. Ranolazine is approved as an antianginal for patients with stable coronary artery disease and is often administered in combination w…